Suppr超能文献

用于构建血管化组织和类器官的微流控生物打印

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids.

作者信息

Zhang Yu Shrike, Pi Qingmeng, van Genderen Anne Metje

机构信息

Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School;

Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; Department of Plastic and Reconstructive Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine.

出版信息

J Vis Exp. 2017 Aug 11(126):55957. doi: 10.3791/55957.

Abstract

Engineering vascularized tissue constructs and organoids has been historically challenging. Here we describe a novel method based on microfluidic bioprinting to generate a scaffold with multilayer interlacing hydrogel microfibers. To achieve smooth bioprinting, a core-sheath microfluidic printhead containing a composite bioink formulation extruded from the core flow and the crosslinking solution carried by the sheath flow, was designed and fitted onto the bioprinter. By blending gelatin methacryloyl (GelMA) with alginate, a polysaccharide that undergoes instantaneous ionic crosslinking in the presence of select divalent ions, followed by a secondary photocrosslinking of the GelMA component to achieve permanent stabilization, a microfibrous scaffold could be obtained using this bioprinting strategy. Importantly, the endothelial cells encapsulated inside the bioprinted microfibers can form the lumen-like structures resembling the vasculature over the course of culture for 16 days. The endothelialized microfibrous scaffold may be further used as a vascular bed to construct a vascularized tissue through subsequent seeding of the secondary cell type into the interstitial space of the microfibers. Microfluidic bioprinting provides a generalized strategy in convenient engineering of vascularized tissues at high fidelity.

摘要

从历史角度来看,构建血管化组织构建体和类器官具有挑战性。在此,我们描述了一种基于微流控生物打印的新方法,以生成具有多层交错水凝胶微纤维的支架。为实现顺畅的生物打印,设计了一种包含复合生物墨水配方的核壳微流控打印头,该配方从核流中挤出,交联溶液由壳流携带,并将其安装到生物打印机上。通过将甲基丙烯酰化明胶(GelMA)与藻酸盐混合,藻酸盐是一种在特定二价离子存在下会发生瞬时离子交联的多糖,随后GelMA组分进行二次光交联以实现永久稳定,使用这种生物打印策略可获得微纤维支架。重要的是,封装在生物打印微纤维内的内皮细胞在16天的培养过程中可形成类似脉管系统的管腔样结构。内皮化的微纤维支架可进一步用作血管床,通过随后将第二种细胞类型接种到微纤维的间隙空间中来构建血管化组织。微流控生物打印为以高保真度方便地构建血管化组织提供了一种通用策略。

相似文献

引用本文的文献

1
Stimuli-responsive hybrid materials for 4D tissue models.用于4D组织模型的刺激响应性杂化材料。
Mater Today Bio. 2025 Jul 2;33:102035. doi: 10.1016/j.mtbio.2025.102035. eCollection 2025 Aug.
3
Engineering the 3D structure of organoids.构建类器官的三维结构。
Stem Cell Reports. 2025 Jan 14;20(1):102379. doi: 10.1016/j.stemcr.2024.11.009. Epub 2024 Dec 19.
4
Organoids in gastrointestinal diseases: from bench to clinic.胃肠道疾病中的类器官:从实验台到临床
MedComm (2020). 2024 Jun 29;5(7):e574. doi: 10.1002/mco2.574. eCollection 2024 Jul.
8
A 3D-Bioprinted Multiple Myeloma Model.3D 生物打印多发性骨髓瘤模型。
Adv Healthc Mater. 2022 Apr;11(7):e2100884. doi: 10.1002/adhm.202100884. Epub 2021 Sep 23.
9
The potential of microfluidics-enhanced extrusion bioprinting.微流控增强挤出生物打印的潜力。
Biomicrofluidics. 2021 Jul 29;15(4):041304. doi: 10.1063/5.0033280. eCollection 2021 Jul.
10
In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.体外策略使 3D 生理相关模型血管化。
Adv Sci (Weinh). 2021 Oct;8(19):e2100798. doi: 10.1002/advs.202100798. Epub 2021 Aug 5.

本文引用的文献

3
Bioprinted thrombosis-on-a-chip.生物打印芯片上的血栓。
Lab Chip. 2016 Oct 18;16(21):4097-4105. doi: 10.1039/c6lc00380j.
7
3D Bioprinting for Tissue and Organ Fabrication.用于组织和器官制造的3D生物打印
Ann Biomed Eng. 2017 Jan;45(1):148-163. doi: 10.1007/s10439-016-1612-8. Epub 2016 Apr 28.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验